Literature DB >> 2455015

Protective and heart-crossreactive epitopes located within the NH2 terminus of type 19 streptococcal M protein.

M S Bronze1, E H Beachey, J B Dale.   

Abstract

M protein was purified to homogeneity from limited pepsin digests of intact type 19 streptococci (pep M19). The purified pep M19 when emulsified in CFA and injected into rabbits evoked type-specific and crossreactive opsonic antibodies, as well as heart-crossreactive antibodies. The NH2-terminal primary structure of pep M19 was determined and a peptide copying the first 24 amino acids [SM19(1-24)C] was chemically synthesized. Rabbits that were immunized with the unconjugated peptide developed antibodies that recognized the native pep M19, as determined by ELISA, and opsonic antibodies against type 19 streptococci, as determined by in vitro opsonophagocytosis tests. The synthetic peptide also evoked antibodies that crossreacted with a 60-kD sarcolemmal membrane protein of human myocardium. By using overlapping synthetic subpeptides as immunoinhibitors, the opsonic and heart-crossreactive epitopes of SM19(1-24)C were localized to SM19(11-24)C. Our data confirm the presence of heart-crossreactive epitopes within the primary structure of pep M19 and show that these potentially harmful autoimmune epitopes may be located in the NH2-terminal regions of certain M proteins. We conclude that continued efforts to identify the primary structures of protective and heart-crossreactive epitopes will be necessary to elucidate the pathogenesis of acute rheumatic heart disease and to develop safe and effective streptococcal vaccines.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2455015      PMCID: PMC2189697          DOI: 10.1084/jem.167.6.1849

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

1.  Primary structure of protective antigens of type 24 streptococcal M protein.

Authors:  E H Beachey; J M Seyer; A H Kang
Journal:  J Biol Chem       Date:  1980-07-10       Impact factor: 5.157

2.  The complete amino acid sequence of a biologically active 197-residue fragment of M protein isolated from type 5 group A streptococci.

Authors:  B N Manjula; A S Acharya; S M Mische; T Fairwell; V A Fischetti
Journal:  J Biol Chem       Date:  1984-03-25       Impact factor: 5.157

3.  Streptococcal M protein: alpha-helical coiled-coil structure and arrangement on the cell surface.

Authors:  G N Phillips; P F Flicker; C Cohen; B N Manjula; V A Fischetti
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

4.  Protective antibody against a peptide fragment of type 5 streptococcal M protein cross-reacts with human heart tissue.

Authors:  J B Dale; E H Beachey
Journal:  Trans Assoc Am Physicians       Date:  1982

5.  Repeating covalent structure and protective immunogenicity of native and synthetic polypeptide fragments of type 24 streptococcal M protein. Mapping of protective and nonprotective epitopes with monoclonal antibodies.

Authors:  E H Beachey; J M Seyer; J B Dale; D L Hasty
Journal:  J Biol Chem       Date:  1983-11-10       Impact factor: 5.157

6.  Heterogeneity of type-specific and cross-reactive antigenic determinants within a single M protein of group A streptococci.

Authors:  J B Dale; I Ofek; E H Beachey
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

7.  Multiple, heart-cross-reactive epitopes of streptococcal M proteins.

Authors:  J B Dale; E H Beachey
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307

8.  Protective antigenic determinant of streptococcal M protein shared with sarcolemmal membrane protein of human heart.

Authors:  J B Dale; E H Beachey
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

9.  Type-specific immunogenicity of a chemically synthesized peptide fragment of type 5 streptococcal M protein.

Authors:  J B Dale; J M Seyer; E H Beachey
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

10.  Location of variable and conserved epitopes among the multiple serotypes of streptococcal M protein.

Authors:  K F Jones; B N Manjula; K H Johnston; S K Hollingshead; J R Scott; V A Fischetti
Journal:  J Exp Med       Date:  1985-03-01       Impact factor: 14.307

View more
  11 in total

1.  Phosphorylase-cross-reactive antibodies evoked by streptococcal M protein.

Authors:  J B Dale; H S Courtney; M Kotb; D Schifferli
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

2.  Systemic and mucosal immunizations with fibronectin-binding protein FBP54 induce protective immune responses against Streptococcus pyogenes challenge in mice.

Authors:  S Kawabata; E Kunitomo; Y Terao; I Nakagawa; K Kikuchi; K Totsuka ; S Hamada
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

Review 3.  Streptococcal M protein: molecular design and biological behavior.

Authors:  V A Fischetti
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

4.  Vimentin-cross-reactive epitope of type 12 streptococcal M protein.

Authors:  W Kraus; J M Seyer; E H Beachey
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

Review 5.  Pathogenesis of group A streptococcal infections.

Authors:  M W Cunningham
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

6.  Reactivity of rheumatic fever and scarlet fever patients' sera with group A streptococcal M protein, cardiac myosin, and cardiac tropomyosin: a retrospective study.

Authors:  K F Jones; S S Whitehead; M W Cunningham; V A Fischetti
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

Review 7.  Molecular Mimicry, Autoimmunity, and Infection: The Cross-Reactive Antigens of Group A Streptococci and their Sequelae.

Authors:  Madeleine W Cunningham
Journal:  Microbiol Spectr       Date:  2019-07

8.  B- and T-cell responses in group a streptococcus M-protein- or Peptide-induced experimental carditis.

Authors:  Davina Gorton; Brenda Govan; Colleen Olive; Natkunam Ketheesan
Journal:  Infect Immun       Date:  2009-03-09       Impact factor: 3.441

9.  Contribution of cryptic epitopes in designing a group A streptococcal vaccine.

Authors:  Victoria Ozberk; Manisha Pandey; Michael F Good
Journal:  Hum Vaccin Immunother       Date:  2018-06-14       Impact factor: 3.452

10.  Pancreatic islet beta cells drive T cell-immune responses in the nonobese diabetic mouse model.

Authors:  E Larger; C Bécourt; J F Bach; C Boitard
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.